Many of the known oncogenes, such as ERBB2, EGFR and CCND1, are frequently amplified [8–12] and many of the known tumor suppressor genes (TSGs), such as CDKN2A, PTEN, NF1 and RB1, are frequently depleted in various types of cancers [13–15]. This evidence concerns the gene PTEN and cancer.